|
|
|
|
 |
|
SENSEX
|
 |
-65.35
|
-0.27%
|
|
24570.65
|
|
|
|
NIFTY
|
 |
-455.59
|
-0.58%
|
|
78499.17
|
|
|
|
Nasdaq
|
 |
342.27
|
1.30%
|
|
26690.62
|
|
|
|
Nikkei 225
|
 |
-76.55
|
-0.12%
|
|
65606.71
|
|
|
|
FTSE 100
|
 |
33.20
|
0.31%
|
|
10901.10
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
BSE Code |
540222
|
|
ISIN Demat |
INE947Q01028
|
|
Book Value (Rs) |
102.14
|
|
|
NSE Code |
LAURUSLABS
|
|
Dividend Yield % |
0.11
|
|
Market Cap (Rs) |
1002279.16
|
|
|
TTM PE(x) |
114.87
|
|
TTM EPS(Rs) |
16.15
|
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
19-09 2005
|
|
Registered Office
|
Laurus Enclave, Plot Office 01,Edulapaka Bonangi Village, Parawada,Mandal, Anakapalli, Vishakhapatnam, Andhra Pradesh-531021 .
|
|
ISINNO
|
INE947Q01028
|
|
Phone
|
0891 6821101 / 1102
|
|
E-mail
|
info@lauruslabs.com |
|
URL
|
www.lauruslabs.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Ravindranath Kancherla
|
|
Managing Director
|
|
|
Company Secretary
|
G Venkateswar Reddy
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|